CLARIVATE PLC (CLVT) — SEC Filings

Latest SEC filings for CLARIVATE PLC (CLVT), explained in plain English.

Sentiment Overview: 2 bullish, 30 neutral, 2 mixed

Recent Filings (34)

4 Filing — 4 · 2026-04-02T17:18:40-04:00 [neutral]
Clarivate Plc Files Form 4 on Ownership Changes — 4 · 2026-04-02T17:18:33-04:00 [neutral] Risk: low
On March 31, 2026, Clarivate Plc reported a statement of changes in beneficial ownership of securities. The filing, dated April 2, 2026, details transactions re
ARS Filing — ARS · 2026-04-01T08:08:41-04:00 [neutral]
Clarivate Plc Files DEFA14A Proxy Materials — DEFA14A · 2026-04-01T08:06:00-04:00 [neutral] Risk: low
Clarivate Plc filed a DEFA14A form on April 1, 2026, related to additional definitive proxy soliciting materials. The filing includes various documents, with th
Clarivate Narrows Losses, Boosts Revenue Slightly in Q3 — 10-Q · 2025-10-29T00:00:00.000Z [mixed] Risk: medium
Clarivate PLC reported a net loss of $28.3 million for the three months ended September 30, 2025, a significant improvement from the net loss of $65.6 million i
Clarivate Plc Enters Material Definitive Agreement — 8-K · 2025-08-05T00:00:00.000Z [neutral] Risk: medium
On August 5, 2025, Clarivate Plc entered into a material definitive agreement, creating a direct financial obligation. The company, incorporated in Jersey, Chan
Clarivate PLC Announces Director Changes and Officer Appointments — 8-K · 2025-07-30T00:00:00.000Z [neutral] Risk: medium
Clarivate Plc announced on July 30, 2025, a series of significant corporate actions effective July 24, 2025. These include the departure of director Jonathan Mi
Clarivate Q2 Earnings Soar on Strong Revenue Growth — 10-Q · 2025-07-30T00:00:00.000Z [bullish] Risk: medium
Clarivate PLC reported a robust financial performance for the second quarter of 2025, with revenue increasing to $690.5 million, up 7.2% from $644.1 million in
Clarivate Plc Reports Board and Executive Changes — 8-K · 2025-07-22T00:00:00.000Z [neutral] Risk: medium
On July 22, 2025, Clarivate Plc filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the departure o
Clarivate Plc Files 8-K: Material Agreement and Financial Updates — 8-K · 2025-06-02T00:00:00.000Z [neutral] Risk: medium
Clarivate Plc entered into a material definitive agreement on May 30, 2025, related to a direct financial obligation. The filing also includes Regulation FD dis
Clarivate Plc Files 8-K — 8-K · 2025-05-19T00:00:00.000Z [neutral] Risk: low
Clarivate Plc filed an 8-K on May 19, 2025, reporting an "Other Events" item. The filing does not contain specific financial transactions or material business u
Clarivate Plc Holds Annual General Meeting — 8-K · 2025-05-12T00:00:00.000Z [neutral] Risk: low
Clarivate Plc announced on May 7, 2025, that it held its Annual General Meeting where shareholders voted on several matters. Key resolutions included the re-app
Clarivate Plc Q1 2025 10-Q Filing — 10-Q · 2025-04-29T00:00:00.000Z [neutral] Risk: low
Clarivate Plc filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance she
Clarivate Plc Files Definitive Proxy Statement — DEF 14A · 2025-03-28T00:00:00.000Z [neutral] Risk: low
Clarivate Plc filed its definitive proxy statement (DEF 14A) on March 28, 2025, for its annual meeting on May 7, 2025. The filing concerns the solicitation of p
Clarivate Appoints New Director, J.P. Garnier — 8-K · 2025-02-28T00:00:00.000Z [neutral] Risk: low
Clarivate Plc announced on February 28, 2025, that its Board of Directors has appointed Dr. J.P. Garnier as a Class II Director, effective February 25, 2025. Dr
Clarivate Plc Files 2024 10-K — 10-K · 2025-02-19T00:00:00.000Z [neutral] Risk: medium
Clarivate Plc filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The filing details the company's financial perfor
Clarivate Plc Files 8-K for Regulatory Disclosures — 8-K · 2024-12-16T00:00:00.000Z [neutral] Risk: low
Clarivate Plc filed an 8-K on December 16, 2024, to report on Regulation FD disclosures and financial statements/exhibits. The filing does not contain specific
Clarivate PLC Files 8-K/A Amendment — 8-K/A · 2024-12-13T00:00:00.000Z [neutral] Risk: low
Clarivate PLC filed an amendment (8-K/A) on December 13, 2024, to a previous filing dated July 23, 2024. This amendment pertains to the departure of directors o
SC 13G/A Filing — SC 13G/A · 2024-12-05T00:00:00.000Z [neutral]
SC 13G Filing — SC 13G · 2024-11-13T00:00:00.000Z [neutral]
Clarivate Plc Files Q3 2024 10-Q Report — 10-Q · 2024-11-06T00:00:00.000Z [neutral] Risk: medium
Clarivate Plc filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key fin
Clarivate PLC Announces Executive and Board Changes — 8-K · 2024-08-06T00:00:00.000Z [neutral] Risk: medium
Clarivate PLC announced on August 1, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and direct
Clarivate Plc Files Q2 2024 10-Q Report — 10-Q · 2024-08-06T00:00:00.000Z [neutral] Risk: medium
Clarivate Plc filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter and the first half of the fiscal year. Key financial data
Clarivate Appoints New CFO, Dr. Marcé Moore — 8-K · 2024-07-24T00:00:00.000Z [neutral] Risk: medium
Clarivate Plc announced on July 24, 2024, that its Board of Directors has appointed Dr. Marcé Moore as Chief Financial Officer, effective July 23, 2024. Dr. Moo
Clarivate Announces $500M Stock Repurchase Program — 8-K · 2024-05-10T00:00:00.000Z [bullish] Risk: low
Clarivate Plc announced on May 7, 2024, that its Board of Directors has approved a new stock repurchase program. The company is authorized to repurchase up to $
Clarivate Plc Files Q1 2024 10-Q — 10-Q · 2024-05-08T00:00:00.000Z [neutral] Risk: medium
Clarivate Plc filed its 10-Q for the period ending March 31, 2024. The filing covers the first quarter of 2024 and provides financial details for the company. K
Clarivate Plc Files 2024 Proxy Statement — DEF 14A · 2024-03-25T00:00:00.000Z [neutral] Risk: low
Clarivate Plc filed its definitive proxy statement (DEF 14A) on March 25, 2024, for its annual meeting on May 7, 2024. The filing details executive compensation
Exor N.V. Amends Clarivate Plc Stake Filing — SC 13D/A · 2024-03-04T00:00:00.000Z [neutral] Risk: medium
Exor N.V. has filed an amendment (No. 4) to its Schedule 13D concerning Clarivate Plc, as of March 4, 2024. The filing indicates a change in beneficial ownershi
Clarivate Plc Files 8-K for Material Definitive Agreement — 8-K · 2024-03-04T00:00:00.000Z [neutral] Risk: medium
On March 4, 2024, Clarivate Plc entered into a Material Definitive Agreement. The filing also includes financial statements and exhibits related to this agreeme
Clarivate PLC Files 2023 Annual 10-K Report — 10-K · 2024-02-27T00:00:00.000Z [neutral] Risk: medium
CLARIVATE PLC filed its 10-K report on February 27, 2024, for the fiscal year ended December 31, 2023. This annual filing provides a comprehensive overview of t
SC 13G/A Filing — SC 13G/A · 2024-02-14T00:00:00.000Z [neutral]
Clarkston Capital Amends Clarivate PLC Stake (SC 13G/A) — SC 13G/A · 2024-02-12T00:00:00.000Z [neutral] Risk: low
Clarkston Capital Partners, LLC, along with its affiliates Clarkston Companies, Inc., Modell Capital LLC, and individuals Gerald W. Hakala, Jeffrey A. Hakala, a
Clarivate PLC Enters Material Agreement, New Financial Obligation — 8-K · 2024-02-01T00:00:00.000Z [mixed]
Clarivate PLC filed an 8-K on February 1, 2024, reporting events that occurred on January 31, 2024. The filing indicates the company entered into a material def
CLARIVATE PLC Files Routine 8-K on Financial Condition — 8-K · 2024-01-22T00:00:00.000Z [neutral]
Clarivate PLC filed an 8-K on January 22, 2024, indicating a routine filing for "Results of Operations and Financial Condition" and "Financial Statements and Ex